Literature DB >> 20009080

Sudden infant death syndrome in mice with an inherited mutation in RyR2.

Nitin Mathur1, Subeena Sood, Sufen Wang, Ralph J van Oort, Satyam Sarma, Na Li, Darlene G Skapura, J Henri Bayle, Miguel Valderrábano, Xander H T Wehrens.   

Abstract

BACKGROUND: Mutations in the cardiac ryanodine receptor gene (RyR2) have been recently identified in victims of sudden infant death syndrome. The aim of this study was to determine whether a gain-of-function mutation in RyR2 increases the propensity to cardiac arrhythmias and sudden death in young mice. METHODS AND
RESULTS: Incidence of sudden death was monitored prospectively in heterozygous knock-in mice with mutation R176Q in RyR2 (R176Q/+). Young R176Q/+ mice exhibited a higher incidence of sudden death compared with wild-type littermates. Optical mapping of membrane potentials and intracellular calcium in 1- to 7-day-old R176Q/+ and wild-type mice revealed an increased incidence of ventricular ectopy and spontaneous calcium releases in neonatal R176Q/+ mice. Surface ECGs in 3- to 10-day-old mice showed that R176Q/+ mice developed more ventricular arrhythmias after provocation with epinephrine and caffeine. Intracardiac pacing studies in 12- to 18-day-old mice revealed the presence of an arrhythmogenic substrate in R176Q/+ compared with wild-type mice. Reverse transcription-polymerase chain reaction and Western blotting showed that expression levels of other calcium handling proteins were unaltered, suggesting that calcium leak through mutant RyR2 underlies arrhythmogenesis and sudden death in young R176Q/+ mice.
CONCLUSIONS: Our findings demonstrate that a gain-of-function mutation in RyR2 confers an increased risk of cardiac arrhythmias and sudden death in young mice and that young R176Q/+ mice may be used as a model for elucidating the complex interplay between genetic and environmental risk factors associated with sudden infant death syndrome.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20009080      PMCID: PMC2796595          DOI: 10.1161/CIRCEP.109.894683

Source DB:  PubMed          Journal:  Circ Arrhythm Electrophysiol        ISSN: 1941-3084


  39 in total

1.  Sudden unexplained death caused by cardiac ryanodine receptor (RyR2) mutations.

Authors:  Xander H T Wehrens; Andrew R Marks
Journal:  Mayo Clin Proc       Date:  2004-11       Impact factor: 7.616

2.  Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients.

Authors:  A V Postma; I Denjoy; J Kamblock; M Alders; J-M Lupoglazoff; G Vaksmann; L Dubosq-Bidot; P Sebillon; M M A M Mannens; P Guicheney; A A M Wilde
Journal:  J Med Genet       Date:  2005-11       Impact factor: 6.318

3.  Near-miss SIDS due to Brugada syndrome.

Authors:  J R Skinner; S-K Chung; D Montgomery; C H McCulley; J Crawford; J French; M I Rees
Journal:  Arch Dis Child       Date:  2005-05       Impact factor: 3.791

4.  Potential role of QT interval prolongation in sudden infant death syndrome.

Authors:  B J Maron; C E Clark; R E Goldstein; S E Epstein
Journal:  Circulation       Date:  1976-09       Impact factor: 29.690

5.  Pathogenesis of unexplained drowning: new insights from a molecular autopsy.

Authors:  David J Tester; Laura J Kopplin; Wendy Creighton; Allen P Burke; Michael J Ackerman
Journal:  Mayo Clin Proc       Date:  2005-05       Impact factor: 7.616

6.  Measurement of heart rate and Q-T interval in the conscious mouse.

Authors:  G F Mitchell; A Jeron; G Koren
Journal:  Am J Physiol       Date:  1998-03

7.  A perspective on neuropathologic findings in victims of the sudden infant death syndrome: the triple-risk model.

Authors:  J J Filiano; H C Kinney
Journal:  Biol Neonate       Date:  1994

8.  Calmodulin kinase II-mediated sarcoplasmic reticulum Ca2+ leak promotes atrial fibrillation in mice.

Authors:  Mihail G Chelu; Satyam Sarma; Subeena Sood; Sufen Wang; Ralph J van Oort; Darlene G Skapura; Na Li; Marco Santonastasi; Frank Ulrich Müller; Wilhelm Schmitz; Ulrich Schotten; Mark E Anderson; Miguel Valderrábano; Dobromir Dobrev; Xander H T Wehrens
Journal:  J Clin Invest       Date:  2009-07       Impact factor: 14.808

9.  Prolongation of the QT interval and the sudden infant death syndrome.

Authors:  P J Schwartz; M Stramba-Badiale; A Segantini; P Austoni; G Bosi; R Giorgetti; F Grancini; E D Marni; F Perticone; D Rosti; P Salice
Journal:  N Engl J Med       Date:  1998-06-11       Impact factor: 91.245

10.  Targeted mutational analysis of the RyR2-encoded cardiac ryanodine receptor in sudden unexplained death: a molecular autopsy of 49 medical examiner/coroner's cases.

Authors:  David J Tester; Daniel B Spoon; Hector H Valdivia; Jonathan C Makielski; Michael J Ackerman
Journal:  Mayo Clin Proc       Date:  2004-11       Impact factor: 7.616

View more
  14 in total

1.  Gene Therapy for Catecholaminergic Polymorphic Ventricular Tachycardia by Inhibition of Ca2+/Calmodulin-Dependent Kinase II.

Authors:  Vassilios J Bezzerides; Ana Caballero; Suya Wang; Yulan Ai; Robyn J Hylind; Fujian Lu; Danielle A Heims-Waldron; Kristina D Chambers; Donghui Zhang; Dominic J Abrams; William T Pu
Journal:  Circulation       Date:  2019-06-03       Impact factor: 29.690

2.  Leaky RyR2 channels unleash a brainstem spreading depolarization mechanism of sudden cardiac death.

Authors:  Isamu Aiba; Xander H T Wehrens; Jeffrey L Noebels
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-01       Impact factor: 11.205

Review 3.  Targeting ryanodine receptors for anti-arrhythmic therapy.

Authors:  Mark D McCauley; Xander H T Wehrens
Journal:  Acta Pharmacol Sin       Date:  2011-06       Impact factor: 6.150

Review 4.  The ryanodine receptor in cardiac physiology and disease.

Authors:  Alexander Kushnir; Andrew R Marks
Journal:  Adv Pharmacol       Date:  2010

5.  Programmed electrical stimulation in mice.

Authors:  Na Li; Xander H T Wehrens
Journal:  J Vis Exp       Date:  2010-05-26       Impact factor: 1.355

6.  Pathogenesis of lethal cardiac arrhythmias in Mecp2 mutant mice: implication for therapy in Rett syndrome.

Authors:  Mark D McCauley; Tiannan Wang; Elise Mike; Jose Herrera; David L Beavers; Teng-Wei Huang; Christopher S Ward; Steven Skinner; Alan K Percy; Daniel G Glaze; Xander H T Wehrens; Jeffrey L Neul
Journal:  Sci Transl Med       Date:  2011-12-14       Impact factor: 17.956

7.  In Vivo Ryr2 Editing Corrects Catecholaminergic Polymorphic Ventricular Tachycardia.

Authors:  Xiaolu Pan; Leonne Philippen; Satadru K Lahiri; Ciaran Lee; So Hyun Park; Tarah A Word; Na Li; Kelsey E Jarrett; Rajat Gupta; Julia O Reynolds; Jean Lin; Gang Bao; William R Lagor; Xander H T Wehrens
Journal:  Circ Res       Date:  2018-09-28       Impact factor: 17.367

Review 8.  Ryanodine receptor phosphorylation, calcium/calmodulin-dependent protein kinase II, and life-threatening ventricular arrhythmias.

Authors:  Mark D McCauley; Xander H T Wehrens
Journal:  Trends Cardiovasc Med       Date:  2011-02       Impact factor: 6.677

9.  An introduction to murine models of atrial fibrillation.

Authors:  Genna Riley; Fahima Syeda; Paulus Kirchhof; Larissa Fabritz
Journal:  Front Physiol       Date:  2012-08-03       Impact factor: 4.566

10.  Cardiac ion channelopathies and the sudden infant death syndrome.

Authors:  Ronald Wilders
Journal:  ISRN Cardiol       Date:  2012-12-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.